Evotec to develop Sanofi candidates in deal worth more than $74m
Sanofi will license more than ten R&D assets to Evotec as part of an open platform alliance designed to advance anti-infective drug discovery and development.
Archives for March 8, 2018
Theradex tapped for two Ph II cancer vaccine trials, releases CTMS
Theradex Oncology will support two Phase II clinical trials evaluating OncBioMune Pharmaceuticals' immunotherapy cancer vaccine and has released a clinical trial management system (CTMS).
Elligo and Saama building new tech platform to catalyze clinical trials
Elligo Health Research is partnering with Saama Technologies to build a new technology platform, which it says will help sponsors achieve their objectives faster.
Teva terminates pain drug development with Xenon
Xenon Pharmaceuticals will regain the full rights to TV-45070 after the topical analgesic failed to meet endpoints in a Phase II trial last year.
EU to suspend AbbVie and Biogen’s MS mAb on back of three deaths
The European Medicines Agency (EMA) has recommended the immediate suspension and recall of AbbVie and Biogen’s multiple sclerosis drug Zinbryta (daclizumab).
Two more OTC makers slammed with US FDA warnings
The US FDA warnings sent to Chinese and Hong Kong-based firms are the latest examples of OTC makers struggling to comply with pharmaceutical standard GMP.